Gå rundt dele Alice gpi anker Switzerland Karakteristisk Annonse Bruke en datamaskin
Heparansulfat-Proteoglykane | SpringerLink
Lipid Anchors to Proteins | SpringerLink
Chemokine-mucin fusions linked to Glycosylphosphatidylinositol (GPI)-anchors in tissue regeneration and as tumour immune adjuvants - Patent 1792914
Lipid moiety of glycosylphosphatidylinositol‐anchored proteins contributes to the determination of their final destination in yeast - Yoko‐o - 2018 - Genes to Cells - Wiley Online Library
Lipid moiety of glycosylphosphatidylinositol‐anchored proteins contributes to the determination of their final destination in yeast - Yoko‐o - 2018 - Genes to Cells - Wiley Online Library
pipette–Swiss Laboratory Medicine, Nr. 1-März 2021: «Benigne» Hämatologie | L'hématologie «bénigne» by SULM - Issuu
Zellkompartimente und Proteintargeting | SpringerLink
PGAP2 Is Essential for Correct Processing and Stable Expression of GPI-anchored Proteins | Molecular Biology of the Cell
Structural analysis of the chimeric CD8-DAF protein. Cells were... | Download Scientific Diagram
Spezies- und gewebespezifischer Nachweis von bovinem ZNS ...
Zellkompartimente und Proteintargeting | SpringerLink
PGAP2 Is Essential for Correct Processing and Stable Expression of GPI-anchored Proteins | Molecular Biology of the Cell
Chemokine-mucin fusions linked to Glycosylphosphatidylinositol (GPI)-anchors in tissue regeneration and as tumour immune adjuvants - Patent 1792914
Proteomic Analysis of Glycosylphosphatidylinositol-anchored Membrane Proteins - ScienceDirect
PGAP2 Is Essential for Correct Processing and Stable Expression of GPI-anchored Proteins | Molecular Biology of the Cell
Phosphorylation of glycosyl-phosphatidylinositol by phosphatidylinositol 3-kinase changes its properties as a substrate for phospholipases - ScienceDirect
GPI-Anker – Wikipedia
Alemtuzumab: eine weitere Chance zur Therapie der Multiplen Sklerose | SpringerLink
Chemokine-mucin fusions linked to Glycosylphosphatidylinositol (GPI)-anchors in tissue regeneration and as tumour immune adjuvants - Patent 1792914